rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia

Journal of Applied Physiology

Volumn 83, Issue 5, 1997, Pages 1467-1475

  Freeman, Bradley D ^a   Quezado, Zenaide ^a   Zeni, Fabrice ^a   Natanson, Charles ^a   Danner, Robert L ^a   Banks, Steven ^a   Quezado, Marcello ^a   Fitz, Yvonne ^a   Bacher, John ^a   Eichacker, Peter Q ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endotoxin; Escherichia coli; Neutrophil; Recombinant granulocyte colony stimulating factor; Sepsis; Septic shock

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DOG; ENDOTOXEMIA; ESCHERICHIA COLI; LEUKOCYTE COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 14444285972     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.5.1467     Document Type: Article

References (40)

1. Baram, D., P. Madara, S. Culpepper, L. Yan, H. L. Malech, and R. L. Danner. Human neutrophils regulate TNF concentrations in monocyte cultures and whole blood (Abstract). Am. J. Respir. Crit. Care Med. 153: A54, 1996.
2. Bersten, A., and W. J. Sibbald. Acute lung injury in septic shock. Crit. Care Clin. 5: 49-77, 1989.
3. Cairo, M. S., D. Mauss, S. Kommareddy, K. Norris, C. Van De Ven, and H. Modanlou. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr. Res. 27: 612-615, 1990.
4. Cole, J. W. L., and J. E. Grizzle. Application of multivariate analysis of variance to repeated measures experiments. Biometrics 22: 810-828, 1966.
5. Cox, D. R., and D. Oakes. Analysis of Survival Data. London: Chapman and Hall, 1984.
6. Danner, R. L., R. J. Elin, J. M. Hosseini, R. A. Wesley, J. M. Reilly, and J. E. Parillo. Endotoxemia in human septic shock. Chest 99: 169-175, 1991.
7. Demuynck, H., P. Zachee, G. E. G. Verhoef, M. Schetz, G. Van Den Berghe, P. Lauwers, and M. A. Boogaerts. Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann. Hematol. 70: 143-147, 1995.
8. Dixon, W. J. Ratios involving extreme valves. Ann. Math. Stat. 22: 68-78, 1951.
9. Eichacker, P. Q., A. Farese, W. D. Hoffman, S. M. Banks, T. Mouginis, S. Richmond, G. C. Kuo, T. J. MacVittie, and C. Natanson. Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. Am. Rev. Respir. Dis. 145: 1023-1029, 1992.
10. Eichacker, P. Q., W. D. Hoffman, A. Farese, S. M. Banks, G. C. Kuo, T. J. MacVittie, and C. Nathanson. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J. Appl. Physiol. 71: 1979-1989, 1991.
11. Eichacker, P. Q., W. D. Hoffman, A. Farese, R. L. Danner, A. F. Suffredini, Y. Waisman, S. M. Banks, T. Mouginis, L. Wilson, R. Rothlein, R. J. Elin, J. M. Hosseini, T. J. MacVittie, and C. Natanson. Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock. J. Appl. Physiol. 74: 1885-1892, 1993.
12. Eichacker, P. Q., and C. Natanson. Rethinking the anti-inflammatory response to septic shock. In: Yearbook of Intensive Care and Emergency Medicine, edited by J. L. Vincent. Frankfurt, Germany: Springer-Verlag, 1996, p. 165-176.
13. Eichacker, P. Q., M. Quezado, F. Zeni, R. Correa, J. Fontana, S. Banks, Y. Fitz, R. L. Danner, and C. Natanson. G-CSF increases or decreases the relative risk of death dependent on site and severity of infection in rats (Abstract). Am. J. Respir. Crit. Care Med. 153: A252, 1996.
14. Eichacker, P. Q., Y. Waisman, C. Natanson, A. Farese, W. D. Hoffman, S. M. Banks, and T. J. MacVittie. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J. Appl. Physiol. 77: 2366-2373, 1994.
15. Erwin, A. L., and R. S. Munford. Processing of LPS by phagocytes. In: Bacterial Endotoxin Lipopolysaccharides, edited by D. C. Morrison and J. Ryan. Boca Raton, FL: CRC, 1992, p. 405-430.
16. Espevik, T., and J. Nissen-Meyer. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. 95: 99-105, 1986.
17. Foster, P. F., D. Mital, H. N. Sankary, L. P. McChesney, J. Marcon, G. Koukoulis, K. Kocess, S. Leurgans, J. F. Whiting, and J. W. Williams. The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 59: 1557-1563, 1995.
18. Freeman, B. D., R. Correa, W. Karzai, C. Natanson, M. Patterson, S. Banks, Y. Fitz, R. L. Danner, L. Wilson, and P. Q. Eichacker. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J. Appl. Physiol. 80: 2066-2076, 1996.
19. Gorgen, I., T. Hartung, M. Leist, M. Niehorster, G. Tiegs, S. Uhlig, F. Weitzel, and A. Wendel. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J. Immunol. 149: 918-924, 1992.
20. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Resources, National Research Council, Department of Health, Education, and Welfare, 1974. (Publ. no. 74-23)
21. Hebert, J. C., M. O'Reilly, and R. L. Gamelli. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch. Surg. 125: 1075-1078, 1990.
22. Kanazawa, M., A. Ishizaka, N. Hasegawa, Y. Suzuki, and T. Yokoyama. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 145: 1030-1035, 1992.
23. King, J., B. P. Deboisblanc, C. M. Mason, J. M. Onoforio, G. Lipscomb, D. E. Mercante, W. R. Summer, and S. Nelson. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am. J. Respir. Crit. Care Med. 151: 302-309, 1995.
24. Lindemann, A., F. Herrmann, W. Oster, G. Haffner, W. Meyenburg, and L. M. Souza. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74: 2644-2651, 1989.
25. Luchi, M., and R. S. Munford. Binding, internalization and deacylation of bacterial lipolysaccharide by human neutrophils. J. Immunol. 151: 959-969, 1993.
26. Lynn, W. A., C. R. Raetz, N. Qureshi, and D. Golenbock. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J. Immunol. 147: 3072-3079, 1991.
27. Natanson, C., P. W. Eichenholz, R. L. Danner, P. Q. Eichacker, W. D. Hoffman, G. C. Kuo, S. M. Banks, T. J. MacVittie, and J. E. Parrillo. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169: 823-832, 1989.
28. Natanson, C., M. P. Fink, H. K. Ballantyne, T. J. MacVittie, J. J. Conklin, and J. E. Parillo. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J. Clin. Invest. 78: 259-270, 1986.
29. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120: 771-783, 1994.
30. Nelson, S., S. Farkas, N. Fotheringham, H. Ho, T. Marrie, and H. Movahhed. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia (CAP) (Abstract). Am. J. Respir. Crit. Care Med. 151: A535, 1996.
31. Nelson, S., W. Summer, G. Bagby, C. Nakamura, L. Stewart, G. Lipscomb, and J. Andresen. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J. Infect. Dis. 164: 901-906, 1991.
32. O'Reilly, M., G. M. Silver, D. G. Greenhalgh, R. L. Gamelli, J. H. Davis, and J. C. Hebert. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J. Trauma 33: 679-682, 1992.
33. Polak-Wyss, A. Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 34: 205-215, 1990.
34. Quezado, M. J. N., Z. Quezado, F. Zeni, C. Natanson, Y. Fitz, S. M. Banks, and P. Q. Eichacker. G-CSF improves and CD11/18 Mab worsens hemodynamics independently during endotoxemia in canines (Abstract). Am. J. Respir. Crit. Care Med. 153: A838, 1996.
35. Quezado, Z. M. N., C. Natanson, W. D. Hoffman, S. M. Banks, R. L. Danner, C. A. Koev, and P. Q. Eichacker. Cardiopulmonary effects of inhaled nitric oxide in canine lobar and diffuse gram-negative pneumonia (Abstract). Crit. Care Med. 21: S210, 1993.
36. Quezado, Z. M. N., C. Natanson, W. D. Hoffman, W. Karzai, C. Koev, R. L. Danner, S. M. Banks, L. Wilson, and P. Q. Eichacker. Granulocyte colony stimulating factor (GCSF) treatment at the onset of E. coli peritonitis-induced septic shock in canines (Abstract). Am. J. Respir. Crit. Care Med. 151: A447, 1995.
37. Rinaldo, J. E., and J. W. Christman. Mechanisms and mediators of the adult respiratory distress syndrome. Clin. Chest Med. 11: 621-632, 1990.
38. Snedcor, G. W., and W. G. Cochran. Statistical Methods. Ames, IA: Iowa State Univ. Press, 1989.
39. Terashima, T., M. Kanazawa, K. Sayama, A. Ishizaka, T. Urano, F. Skamaki, H. Nakamura, Y. Waki, and S. Tasaka. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am. J. Respir. Crit. Care Med. 149: 1295-1303, 1994.
40. Yasuda, H., Y. Ajiki, T. Shimozato, M. Kasahara, H. Kawada, M. Iwata, and K. Shimizu. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect. Immun. 58: 2502-2509, 1990.